Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda

Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda

Treatment outcomes of HIV patients receiving antiretroviral therapy (ART) in Rwanda are scarcely documented. HIV viral load (VL) and HIV drug-resistance (HIVDR) outcomes at month 12 were determined in a prospective cohort study of antiretroviral–naïve HIV patients initiating first-line therapy in Ki...

Full description

Bibliographic Details
Main Authors: Rusine, John, Asiimwe-Kateera, Brenda, van de Wijgert, Janneke, Boer, Kimberly Rachel, Mukantwali, Enatha, Karita, Etienne, Gasengayire, Agnes, Jurriaans, Suzanne, de Jong, Menno, Ondoa, Pascale
Format: Online
Language:English
Published: Public Library of Science 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741294/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741294/

Similar Items